Download History of Perfusion - cardiac anesthesia basics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Men who have sex with men blood donor controversy wikipedia , lookup

Plateletpheresis wikipedia , lookup

Transcript
History of Perfusion
Brian Schwartz, CCP
September 2, 2003
Perfusion I
Introduction
• Before 1952 Physicians had no means of
treating patients with intracardiac
malformations
• With the development of the heart and
lung machine, surgeons were able to
operate on patients who were once
considered “non-operatable”
Historical Time-Line
• 1952: Lewis performed the first open heart
surgery (repair of an ASD).
• Used inflow occlusion and general hypothermia
• 1953: Gibbon performed many cases
utilizing CPB; yet he only had one success
• 1954: Lillehei used “cross-circulation” for
the closure of a VSD
Historical Time-Line (cont)
• Late 1950’s: Kirklin used the film
oxygenator in a large number of patients
• May of 1955: The DeWall-Lillehei bubble
oxygenator became the method of choice
to oxygenate venous blood during open
heart surgery
• Membrane oxygenator developed and
used from the 50’s to the 70’s
Historical Time-Line (cont)
• 1980’s: Design changed with regards to
the membrane oxygenator…now
microporous, making it the choice of
oxygenators
• Priming the heart and lung machines with
non-blood solutions was a major advance
in heart sugery
• Improved tissue perfusion
• Reduced hemolysis
• Avoided exposure to donor blood
Reasons Why Initial Results were
Discouraging
• Flow rates were too high
• Poor visibility
• Pumping air to patient
Controlled Cross-Circulation for
Cardiopulmonary Bypass
• The thought of using “cross-circulation” for
cardiac surgery led to huge debates within
the medical community
• With this method physicians used a
“normal human being” to provide donor
circulation
• This technique for ECC was utilized for 45
operations, with no donor
mortality/morbidity.